Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To conduct component network meta‐analyses (cNMAs) to investigate the comparative effectiveness, safety and tolerability of different smoking cessation pharmacotherapies and electronic cigarettes (EC), singly and combined, when helping people to stop smoking tobacco. To investigate: how the different characteristics of smoking cessation pharmacotherapies and EC interventions (e.g. intervention subtype, dose, length of intervention, whether the intervention is used prequit as well as from quit date or from quit date only) influence efficacy, safety and tolerability; whether identifiable participant characteristics and behavioural support suggest different optimal intervention strategies.

Original publication

DOI

10.1002/14651858.cd015226

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publisher

Cochrane Collaboration

Publication Date

30/03/2022

Volume

2022

Keywords

FFR